WEBINAR

Find patented antibodies and antibody-drug conjugates through keywords, biosequences and small molecule searches

Published, 13 March 2020

Antibody patent searching is a complex task

You need to consider their target, their name (if any), the heavy and light chain sequences and the CDR sequences.

We will demonstrate how to perform those queries in Orbit Intelligence.

When antibody-drug conjugates (ADC) are taken into account, then we also need to consider chemistry elements and some specific keywords in the search.

Orbit Intelligence allows you to combine searches of any type and to rapidly retrieve and analyze the desired results.

Agenda:

  1. Antibodies and antibody-drug conjugates in patents
  2. Linkers and warheads
  3. Antibody sequences
  4. Putting it all together

 

SPEAKERS

Watch our video
BLOG POST

NFTs and trademarks, the metaverse and your IP

Intellectual Property

Blockchain and NFTs have many potential implications for IP rights. Here, we summarize the main IP risks and opportunities for owners of NFTs and trademarks. 

BLOG POST

China copyright infringement case: China issues first court ruling on NFTs

Intellectual Property

On 20 April, the Hangzhou Internet Court in East China held a public hearing to resolve a dispute over the copyright infringement of an NFT digital collection listed on a Chinese NFT marketplace, BigVerse. IP lawyer Xuemin Lu explains the implications of the ruling.  The artwork at the center of the China copyright infringement dispute… Read More »China copyright infringement case: China issues first court ruling on NFTs

WEBINAR

Unified Patent Court – All you need to know about opt-outs

Intellectual Property

In the 3 month “sunrise” period before the new system starts, most likely at the end of 2022 or beginning of 2023, applicants and patentees can exclude or “opt-out” their in force and expired European patents, their patent applications and Supplementary Protection Certificates from the UPC’s jurisdiction..